Fascination About who makes copyright and rybelsus
A study posted in JAMA Network Open up emphasizes the discrepancy among what it prices to supply copyright and the retail selling prices patients encounter. Regardless of the lower creation prices, Novo Nordisk has not publicly disclosed specific figures for copyright or its other item, Wegovy.Novo Nordisk is involved with federal government funded